Deborah Birx
Chief Executive Officer at ARMATA PHARMACEUTICALS, INC.
Net worth: 2 M $ as of 30/05/2024
Deborah Birx active positions
| Companies | Position | Start | End |
|---|---|---|---|
| ARMATA PHARMACEUTICALS, INC. | Director/Board Member | 10/07/2023 | - |
| Chief Executive Officer | 10/07/2023 | - | |
Nanolive SA
 Nanolive SA Medical SpecialtiesHealth Technology Nanolive SA develops revolutionary tomographic microscope to look instantly inside living cells in 3D. Its device scans cell division, cell organelles and cell morphology, cell differentiation, cell-cell interaction, intracellular trafficking, cellular remodeling processes, drug monitoring, and in vitro fertilization. The company was founded in November 2013 by Yann Cotte, Sebastien Equis, and Andreas Kern, Fatih Toy, Christian Depeursinge and is headquartered in Ecublens, Switzerland. | Director/Board Member | - | - |
Career history of Deborah Birx
Former positions of Deborah Birx
| Companies | Position | Start | End |
|---|---|---|---|
| INNOVIVA, INC. | Director/Board Member | 08/03/2021 | 09/07/2023 |
| Independent Dir/Board Member | 08/03/2021 | 09/07/2023 |
Training of Deborah Birx
| Houghton College | Undergraduate Degree |
| Pennsylvania State University College of Medicine | Doctorate Degree |
Statistics
International
| United States | 5 |
| Switzerland | 2 |
Operational
| Director/Board Member | 3 |
| Independent Dir/Board Member | 1 |
| Undergraduate Degree | 1 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| INNOVIVA, INC. | Health Technology |
| ARMATA PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Nanolive SA
Nanolive SA Medical SpecialtiesHealth Technology Nanolive SA develops revolutionary tomographic microscope to look instantly inside living cells in 3D. Its device scans cell division, cell organelles and cell morphology, cell differentiation, cell-cell interaction, intracellular trafficking, cellular remodeling processes, drug monitoring, and in vitro fertilization. The company was founded in November 2013 by Yann Cotte, Sebastien Equis, and Andreas Kern, Fatih Toy, Christian Depeursinge and is headquartered in Ecublens, Switzerland. | Health Technology |
- Stock Market
- Insiders
- Deborah Birx
- Experience
